Evidence map›Paper›PMID 38470058›Full record

ArticleJournal of virology2024

ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.

Miriam Ruth Heindl, Anna-Lena Rupp, Marie Schwerdtner, Dorothea Bestle, Anne Harbig, Amy De Rocher, Luna C Schmacke, Bart Staker, Torsten Steinmetzer, David A Stein and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Miriam Ruth HeindlInstitute of Virology, Philipps-University, Marburg, Germany.
Anna-Lena RuppInstitute of Virology, Philipps-University, Marburg, Germany.
Marie SchwerdtnerInstitute of Virology, Philipps-University, Marburg, Germany.
Dorothea BestleInstitute of Virology, Philipps-University, Marburg, Germany.
Anne HarbigInstitute of Virology, Philipps-University, Marburg, Germany.
Amy De RocherSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.
Luna C SchmackeInstitute of Pharmaceutical Chemistry, Philipps-University, Marburg, Germany.
Bart StakerSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.
Torsten SteinmetzerInstitute of Pharmaceutical Chemistry, Philipps-University, Marburg, Germany.
David A SteinDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Hong M MoultonDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Eva Böttcher-FriebertshäuserInstitute of Virology, Philipps-University, Marburg, Germany.ORCID 0000-0002-0007-8110
Philipps University of Marburg · DECenter for Infectious Disease Research · USOregon State University · US

Funding

Centers for Research on Structural Biology of Infectious Diseases: Universal Influenza Vaccine Research75N93022C00036 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI STAKER, BART · 2022 to 2025
$21.7M
NIAID NIH HHS 75N93022C00036
6 · The paper itself

Abstract

The transmembrane serine protease 2 (TMPRSS2) activates the outer structural proteins of a number of respiratory viruses including influenza A virus (IAV), parainfluenza viruses, and various coronaviruses for membrane fusion. Previous studies showed that TMPRSS2 interacts with the carboxypeptidase angiotensin-converting enzyme 2 (ACE2), a cell surface protein that serves as an entry receptor for some coronaviruses. Here, by using protease activity assays, we determine that ACE2 increases the enzymatic activity of TMPRSS2 in a non-catalytic manner. Furthermore, we demonstrate that ACE2 knockdown inhibits TMPRSS2-mediated cleavage of IAV hemagglutinin (HA) in Calu-3 human airway cells and suppresses virus titers 100- to 1.000-fold. Transient expression of ACE2 in ACE2-deficient cells increased TMPRSS2-mediated HA cleavage and IAV replication. ACE2 knockdown also reduced titers of MERS-CoV and prevented S cleavage by TMPRSS2 in Calu-3 cells. By contrast, proteolytic activation and multicycle replication of IAV with multibasic HA cleavage site typically cleaved by furin were not affected by ACE2 knockdown. Co-immunoprecipitation analysis revealed that ACE2-TMPRSS2 interaction requires the enzymatic activity of TMPRSS2 and the carboxypeptidase domain of ACE2. Together, our data identify ACE2 as a new co-factor or stabilizer of TMPRSS2 activity and as a novel host cell factor involved in proteolytic activation and spread of IAV in human airway cells. Furthermore, our data indicate that ACE2 is involved in the TMPRSS2-catalyzed activation of additional respiratory viruses including MERS-CoV.IMPORTANCEProteolytic cleavage of viral envelope proteins by host cell proteases is essential for the infectivity of many viruses and relevant proteases provide promising drug targets. The transmembrane serine protease 2 (TMPRSS2) has been identified as a major activating protease of several respiratory viruses, including influenza A virus. TMPRSS2 was previously shown to interact with angiotensin-converting enzyme 2 (ACE2). Here, we report the mechanistic details of this interaction. We demonstrate that ACE2 increases or stabilizes the enzymatic activity of TMPRSS2. Furthermore, we describe ACE2 involvement in TMPRSS2-catalyzed cleavage of the influenza A virus hemagglutinin and MERS-CoV spike protein in human airway cells. These findings expand our knowledge of the activation of respiratory viruses by TMPRSS2 and the host cell factors involved. In addition, our results could help to elucidate a physiological role for TMPRSS2.

Indexed as

Angiotensin-Converting Enzyme 2Influenza A virusLungProteolysisSerine EndopeptidasesAnimalsBiocatalysisCell LineDogsFurinHemagglutinin Glycoproteins, Influenza VirusHumansMiddle East Respiratory Syndrome CoronavirusProtein BindingSpike Glycoprotein, CoronavirusVirus InternalizationACE2 protein, humanAngiotensin-Converting Enzyme 2FurinHemagglutinin Glycoproteins, Influenza VirusSerine EndopeptidasesSpike Glycoprotein, CoronavirusTMPRSS2 protein, humanACE2hemagglutinin cleavagehost cell proteasesinfluenza A virusTMPRSS2virus activation

Identifiers

PMID38470058
PMCPMC11019950
OpenAlexW4392715742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.